HIMMELSBACH, FRANK,LANGKOPF, ELKE,WAGNER, HOLGER,REDEMANN, FRANK
申请号:
PL14738531
公开号:
PL3022210T3
申请日:
2014.07.14
申请国别(地区):
PL
年份:
2018
代理人:
摘要:
The present invention relates to compounds of general formula I, wherein the group R1, R2, X and Y are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the AMP-activated protein kinase (AMPK) and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.